Phibro Animal Health (NASDAQ:PAHC) Posts Earnings Results, Misses Expectations By $0.02 EPS

Phibro Animal Health (NASDAQ:PAHCGet Rating) announced its quarterly earnings data on Wednesday. The company reported $0.33 earnings per share for the quarter, missing analysts’ consensus estimates of $0.35 by ($0.02), MarketWatch Earnings reports. Phibro Animal Health had a net margin of 6.48% and a return on equity of 21.73%. During the same period in the previous year, the business posted $0.34 earnings per share.

Shares of PAHC opened at $18.73 on Friday. Phibro Animal Health has a 12 month low of $17.28 and a 12 month high of $31.00. The stock’s 50-day moving average is $19.71 and its two-hundred day moving average is $20.43. The company has a debt-to-equity ratio of 1.62, a current ratio of 3.05 and a quick ratio of 1.67. The stock has a market cap of $758.57 million, a PE ratio of 12.92 and a beta of 0.56.

The company also recently declared a quarterly dividend, which will be paid on Wednesday, June 22nd. Shareholders of record on Wednesday, June 1st will be given a dividend of $0.12 per share. This represents a $0.48 dividend on an annualized basis and a yield of 2.56%. The ex-dividend date of this dividend is Tuesday, May 31st. Phibro Animal Health’s dividend payout ratio (DPR) is presently 33.10%.

Several equities research analysts recently issued reports on the stock. Barclays upgraded shares of Phibro Animal Health from an “underweight” rating to an “equal weight” rating and set a $23.00 price objective for the company in a research report on Monday, January 10th. StockNews.com cut shares of Phibro Animal Health from a “strong-buy” rating to a “buy” rating in a research report on Thursday.

A number of institutional investors have recently added to or reduced their stakes in the business. Morgan Stanley boosted its holdings in shares of Phibro Animal Health by 210.1% during the second quarter. Morgan Stanley now owns 180,782 shares of the company’s stock worth $5,222,000 after purchasing an additional 122,489 shares during the period. Charles Schwab Investment Management Inc. boosted its position in Phibro Animal Health by 28.5% during the fourth quarter. Charles Schwab Investment Management Inc. now owns 195,730 shares of the company’s stock worth $3,997,000 after purchasing an additional 43,358 shares during the period. Invesco Ltd. boosted its holdings in shares of Phibro Animal Health by 2.0% during the fourth quarter. Invesco Ltd. now owns 169,489 shares of the company’s stock worth $3,461,000 after acquiring an additional 3,353 shares during the period. Parametric Portfolio Associates LLC grew its position in shares of Phibro Animal Health by 4.5% in the fourth quarter. Parametric Portfolio Associates LLC now owns 102,889 shares of the company’s stock valued at $2,101,000 after purchasing an additional 4,418 shares during the last quarter. Finally, D. E. Shaw & Co. Inc. lifted its holdings in shares of Phibro Animal Health by 12.3% during the fourth quarter. D. E. Shaw & Co. Inc. now owns 72,450 shares of the company’s stock worth $1,479,000 after buying an additional 7,952 shares in the last quarter. 50.06% of the stock is owned by hedge funds and other institutional investors.

About Phibro Animal Health (Get Rating)

Phibro Animal Health Corporation develops, manufactures, and supplies a range of animal health and mineral nutrition products for livestock primarily in the United States. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets products for a range of food animals, including poultry, swine, beef and dairy cattle, and aquaculture.

Featured Articles

Earnings History for Phibro Animal Health (NASDAQ:PAHC)

Receive News & Ratings for Phibro Animal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Phibro Animal Health and related companies with MarketBeat.com's FREE daily email newsletter.